FDA Issues Guidance for Conducting Clinical Trials

Yesterday the FDA issued a new guidance on conducting clinical trials. Click here to read the press release and guidance.

What this means for you:

With the recent updates and guidelines we have been monitoring for our industry, the FDA will necessarily issue guidance as medicines and treatments are being researched and tested. It is critical to follow Good Clinical Practice to avoid the warning letters that we have seen since the COVID-19 pandemic.

Learn more about our GCP thoughts and other solutions we have developed over the last two decades of helping our industry navigate clinical trials in a way that makes sense to develop processes designed to avoid regulatory compliance issues.

The Compliance Insight Team


Gain Our Insight


Be in Touch


e. info@compliance-insight.com

p. (513) 860 - 3512

© 2020 by Compliance Insight

All Rights Reserved  |  Contact Us

Corporate Headquarters


497 Circle Freeway Suite 230

Cincinnati, Ohio 45246

Business Hours


Monday - Friday 

8:30am EST - 5:30pm EST

  • facebook
  • linkedin
  • twitter
  • youtube